Eledon Pharmaceuticals, Inc. (ELDN) stock
ELDNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.12−0.25 (-10.57%)
Close on Nov 13, 2026Market cap $171.87MP/E –Yield –
Eledon Pharmaceuticals ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Eledon Pharmaceuticals's ebitda for the twelve months ending Dec 31, 2020 was -$18.46M. For fiscal 2020 it was -$18.46M. The highest annual figure on record is -$5.09M in fiscal 2016.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | -$18.46M | – |
| FY2019 | Dec 31, 2019 | -$16.04M | – |
| FY2018 | Dec 31, 2018 | -$14.05M | – |
| FY2017 | Dec 31, 2017 | -$13.10M | – |
| FY2016 | Dec 31, 2016 | -$5.09M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2020 | Dec 31, 2020 | -$6.35M | – |
| Q3 FY2020 | Sep 30, 2020 | -$6.15M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.59M | – |
| Q1 FY2020 | Mar 31, 2020 | -$3.38M | – |
| Q4 FY2019 | Dec 31, 2019 | -$4.17M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.92M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.09M | – |
| Q1 FY2019 | Mar 31, 2019 | -$4.87M | – |
| Q4 FY2018 | Dec 31, 2018 | -$4.57M | – |
| Q3 FY2018 | Sep 30, 2018 | -$3.50M | – |
| Q2 FY2018 | Jun 30, 2018 | -$3.19M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.79M | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.10M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.96M | – |
| Q2 FY2017 | Jun 30, 2017 | -$6.65M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.38M | – |
| Q4 FY2016 | Dec 31, 2016 | -$3.74M | – |
See a number that looks wrong?